Φορτώνει......
Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?
In resectable colorectal liver metastasis (CRLM) the role and use of molecular biomarkers is still controversial. Several biomarkers have been linked to clinical outcomes in CRLM, but none have so far become routine for clinical decision making. For several reasons, the clinical risk score appears t...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | World J Gastrointest Oncol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Baishideng Publishing Group Inc
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348630/ https://ncbi.nlm.nih.gov/pubmed/28344745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v9.i3.98 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|